Braxia Scientific Corp.
BRAX.CN
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.42M
Close$
Share Statistics
| Market cap | $1.42 Million |
|---|---|
| Enterprise Value | $2.08 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 1.44 |
| Outstanding Shares | 263,708,939 |
Return
| Return on Equity | 2635.03% |
|---|---|
| Return on Assets | -412.24% |
| Return on Invested Capital | -3118.07% |
Valuation & Multiples
| P/E Ratio | -0.09 |
|---|---|
| PEG | 0.15 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 0.94 |
| Enterprise Value to EBIT | -0.49 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | -2.16 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Braxia Scientific Corp.
5 employees
CEO: Peter Rizakos Braxia Scientific Corp. functions as a medical research entity that also runs clinics, offering ketamine therapies to individuals suffering from depression and linked conditions. Beyond its clinical services, the company is actively enga...